Fonar (FONR) Stock Analysis & Winston Score
Fonar Corporation makes MRI (magnetic resonance imaging) machines used by doctors to scan patients without surgery. Its most well-known product is the Stand-Up MRI, which lets patients be scanned while standing, sitting, or bending — positions that can reveal problems traditional lying-down MRI machines might miss. Fonar sells its equipment to hospitals, imaging centers, and physician groups, primarily in the United States. Fonar earns money by selling MRI machines and by providing management services to MRI scanning centers through its subsidiary, Health Management Corporation of America. Most of its revenue comes from managing these centers rather than just selling hardware. The company is small, with a market cap around $100 million, and its niche focus on weight-bearing MRI gives it a narrow but defensible position in a market dominated by much larger companies like GE and Siemens. The main risk is its limited scale, which makes it vulnerable to competition, reimbursement policy changes from insurers, and any slowdown in demand for specialty imaging services.
Winston Score: 42/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (12/30)
- Growth: Weak (3/20)
- Cash Flow: Strong (7/10)
- Stability: Good (5/10)
- Valuation: Mixed (4/10)
- Ownership: Good (10/15)


